Berman Capital Advisors’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
$1K Buy
102
+33
+48% +$324 ﹤0.01% 1881
2021
Q2
$1K Buy
+69
New +$1K ﹤0.01% 1747